Clinical efficacy and safety: Allergy/Immunology

  • Email
  • Help

This page lists the European Medicines Agency's scientific guidelines on the clinical safety and efficacy of medicines used for allergies and related diseases of the immune system. 

If you have comments on a document which is open for consultation, please use the form for submission of comments on scientific guidelines.

Please note that the EWP Secretariat email address (ewpsecretariat@ema.europa.eu) no longer exists. Therefore, please submit your comments from now on to the following email address: riwpsecretariat@ema.europa.eu.

TopicDocumentsReference numberPublication dateEffective dateRemarks
Clinical development of products for specific immunotherapy for the treatment of allergic diseases

Overview of comments

Adopted guideline

Draft guideline

Concept paper

CHMP/EWP/18504/06Nov 2008Jun 2009 
Clinical investigation of immunosuppressants for solid organ transplantation

Overview of comments

Adopted guideline

Draft guideline

Concept paper

CHMP/EWP/263148/06Sep 2008Feb 2009 
Clinical Development of Medicinal Products for the Treatment of Allergic Rhino-conjunctivitisAdopted guidelineCPMP/EWP/2455/02Oct 2004May 2005 

How useful is this page?

Average rating:

 Based on 9 ratings

Add your rating:

See all ratings
7 ratings
0 ratings
0 ratings
1 ratings
1 ratings